M. F. Kıncı, Ercan Saruhan, Ezgi Karakas Paskal, B. E. Çitil, Burak Sezgin
{"title":"我院孕妇刚地弓形虫、风疹和巨细胞病毒血清阳性率分析","authors":"M. F. Kıncı, Ercan Saruhan, Ezgi Karakas Paskal, B. E. Çitil, Burak Sezgin","doi":"10.47572/muskutd.1078037","DOIUrl":null,"url":null,"abstract":"To determine the rate of seropositivity in toxoplasma, rubella and cytomegalovirus infections during pregnancy. 4488 pregnants who applied to Outpatient polyclinics of Gynecology and Obstetrics in Muğla Sıtkı Koçman University Training and Research Hospital for pregnancy examination in the first 10 weeks of pregnancy were included in the study. Results of anti-Toxoplasma IgM and IgG, anti-Rubella IgM and IgG, anti-CMV IgM and IgG were evaluated. Seropositivity rates of anti-Toxoplasma, anti-Rubella, anti-CMV IgG and IgM were determined respectively 21.6%, 1.6%, 92.8%, 1%; 98.5%, 1.1% in the study group. Toxoplasma, Rubella and CMV seroprevalence should be evaluated during preconceptional or antenatal screening according to regional conditions.","PeriodicalId":153630,"journal":{"name":"Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi","volume":"35 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Seroprevalence of Toxoplasma gondii, Rubella and Cytomegalovirus among pregnant women in our hospital\",\"authors\":\"M. F. Kıncı, Ercan Saruhan, Ezgi Karakas Paskal, B. E. Çitil, Burak Sezgin\",\"doi\":\"10.47572/muskutd.1078037\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To determine the rate of seropositivity in toxoplasma, rubella and cytomegalovirus infections during pregnancy. 4488 pregnants who applied to Outpatient polyclinics of Gynecology and Obstetrics in Muğla Sıtkı Koçman University Training and Research Hospital for pregnancy examination in the first 10 weeks of pregnancy were included in the study. Results of anti-Toxoplasma IgM and IgG, anti-Rubella IgM and IgG, anti-CMV IgM and IgG were evaluated. Seropositivity rates of anti-Toxoplasma, anti-Rubella, anti-CMV IgG and IgM were determined respectively 21.6%, 1.6%, 92.8%, 1%; 98.5%, 1.1% in the study group. Toxoplasma, Rubella and CMV seroprevalence should be evaluated during preconceptional or antenatal screening according to regional conditions.\",\"PeriodicalId\":153630,\"journal\":{\"name\":\"Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi\",\"volume\":\"35 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47572/muskutd.1078037\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47572/muskutd.1078037","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Seroprevalence of Toxoplasma gondii, Rubella and Cytomegalovirus among pregnant women in our hospital
To determine the rate of seropositivity in toxoplasma, rubella and cytomegalovirus infections during pregnancy. 4488 pregnants who applied to Outpatient polyclinics of Gynecology and Obstetrics in Muğla Sıtkı Koçman University Training and Research Hospital for pregnancy examination in the first 10 weeks of pregnancy were included in the study. Results of anti-Toxoplasma IgM and IgG, anti-Rubella IgM and IgG, anti-CMV IgM and IgG were evaluated. Seropositivity rates of anti-Toxoplasma, anti-Rubella, anti-CMV IgG and IgM were determined respectively 21.6%, 1.6%, 92.8%, 1%; 98.5%, 1.1% in the study group. Toxoplasma, Rubella and CMV seroprevalence should be evaluated during preconceptional or antenatal screening according to regional conditions.